Long-chain dialkyl phthalates (Kluwe et al., 1982 (Kluwe et al., , 1983 and some hypolipidemic drugs (Reddy & Rao, 1977; Reddy & Qureshi, 1979; Fitzgerald et al., 1981) have produced liver cancer in rats and mice following administration for a prolonged period at high dose levels. These agents have also been described as peroxisome proliferators in rodent liver (Reddy et al., 1974; Leighton et al., 1975) and it has been suggested that peroxisome proliferators as a class are carcinogenic . Peroxisome proliferating agents are also associated with an increase in the activities of some enzymes, i.e. cyanide-insensitive palmityol-CoA dehydrogenase (usually termed peroxisomal ,Boxidation), catalase, carnitine acetyltransferase and cytosolic palmitoyl-CoA hydrolase (Reddy et al., 1974; Moody & Reddy, 1978; Inestrosa et al., 1979; Berge et al., 1981; Berge & Bakke, 1981; Berge et al., 1983) . Hypolipidemic drugs as well as phthalates have been found not to be genotoxic (Warren et al., 1980; Von Daniken et al., 1984) . Thus, these compounds may be termed epigenetic carcinogens. The negative results in genotoxicity assays suggested that peroxisome proliferators may have exerted their weak carcinogenic response through a promotional mechanism. Therefore, it would be of interest to establish whether a classical tumour promoter exerts a peroxisomal effect.
12-O-tetradecanoylphorbol-13-acetate (TPA) is a potent tumour promoter and it is the most active Correspondence: R.K. Berge. Received 25 June 1985; and in revised form, 7 Octobcr 1985. phorbol ester examined. The molecular mechanism of action of tumour promoters are not fully understood. TPA appears to be a membrane active agent, presumably through its interaction with highaffinity, saturable receptors. These receptors appear to be the calcium and lipid binding protein kinase C that is activated by TPA (Hicks, 1983; Blumberg, 1981) . TPA also alters the metabolism of the intracellular membrane components. A specific enhancement of choline incorporation into the nuclear associated reticulum of the C3H/1OT1/2 C18 cells has been reported (Pryme et al., 1983) . Backer et al. (1982) have shown that TPA inhibits mitochondrial respiration in C3H/IOTI/2 mouse fibroblasts at nanomolar concentrations. Moreover, TPA has been shown to increase generation of 02 and H202 and chemiluminescence (Goldstein et al., 1975; Kensler & Trush, 1981) . However, there is considerable speculation on the role of 02 in carcinogenesis. Thus it is still unproven whether reactive oxygen species appear to have a role in the multiple steps in chemical carcinogenesis and their involvement in the mechanism of tumour promotion by TPA. Increased H202 generation has been observed in the livers of rats administered peroxisome proliferators (Lalwani et al., 1981) . Prolonged exposure to peroxisome proliferators results in the excessive accumulation of autofluorescent lipofusion in the liver (Reddy et al., 1982) tumour promoters when assayed in mouse embryo fibroblasts C3H/IOT1/2 C18 cells . The purpose of this study was therefore to investigate the response of these cells to a known peroxisome proliferator and to TPA. Peroxisomal changes were assessed by measuring the biochemical markers for peroxisomal fl-oxidation, carnitine acetyltransferase, catalase and palmitoylCoA hydrolase. The present study shows that TPA treatment selectively enhanced the activities of these peroxisome-associated enzymes, but not NADPHcytochrome c reductase and glutamate dehydrogenase, thus providing indirect evidence that TPA, a tumour promoter, can also be a peroxisomeproliferating agent. [1-`4C] palmitoyl-CoA was purchased from New England Nuclear, Boston, MA, USA. TPA was obtained from PL/Biochemicals, USA. Tiadenol was a gift from Laboratorios Almirall, Barcelona, Spain. All other chemicals were of highest purity commercially available.
Materials and methods

Results
With a prepared postnuclear fraction of mouse embryo fibroblast C3H/IOT1/2 C18 cells, the hydrolysis of palmitoyl-CoA was linear with the amount of protein up to -50 pg (Figure 1 ). The rate of hydrolysis of palmitoyl-CoA by the corresponding cell fraction was constant up to -6 min (data not shown). When the C18 cells were cultured in the presence of a non-toxic concentration of TPA (20 nM) for 9 days, the specific activity of the palmitoyl-CoA hydrolase activity (24.6 nmol min-' mg-' protein) was increased -2.5 fold compared to control cells (9.7 nmol min-mg-1 protein) (Figure 1 ). Tiadenol administration, a potent hypolipidemic drug (Berge & Bakke, 1981) also enhanced this enzyme activity in the C18 cells and MCA16 cells . When the C18 cells were cultured in the presence of 2OnM TPA for 24 h, the activity of the palmitoyl-CoA hydrolase activity declined -30% (Figure 2 ). However, after this period there was a progressive increase in palmitoyl-CoA hydrolase activity up to 240h. The palmitoyl-CoA hydrolase specific activity of untreated cells was constant during this growth period. For . The control values at time zero for palmitoyl-CoA hydrolase and catalase activities were 12 nmol min-I mg-1 protein and 10 nmol min 1mg ' protein, respectively. 0 possibly due to a larger portion of the cells entering the G1/Go-phase . The palmitoyl-CoA hydrolase activity was also enhanced in the chemically transformed C3H/IOT1/2 MCA16 cells after TPA addition (Figure 2 ). Compared to control C18 cells the treatment of TPA decreased the catalase activity 50% the first 120 h, but for longer incubation times (240 h) the specific activity of catalase, a peroxisome-associated enzyme, was enhanced 1.8
fold.
When mouse embryo fibroblast C18 cells were grown in the presence of 20 nM TPA for up to 240 h, progressive increased activities of both cyanide-insensitive palmitoyl-CoA dehydrogenase and carnitine acetyltransferase (two specific enzymes for peroxisome proliferation) were obtained ( aThe activity was measured in the nuclear fraction. bThe activity was measured in the whole homogenate.
A number of systems have been proposed as models for in vitro promotion; of these mouse embryo fibroblast C3H/IOT1/2 cells have been well characterized (Reznikoff et al., 1973; Mondal & Heidelberger, 1976; Lillehaug & Djurhuss, 1982) . Exposure of these cells at low density to carcinogenic agents such as polycyclic hydrocarbons, ultra-violet irradiation or X-rays at subcarcinogenic doses followed by sustained exposure to phorbol esters such as TPA results in augmented formation of transformed foci.
A marked stimulation of cyanide-insensitive palmitoyl-CoA oxidation, carnitine acetyltransferase and palmitoyl-CoA hydrolase activities with a moderate enhancement of the catalase activity, is characteristic of the preferential stimulation of peroxisomal enzymes associated with fatty acid metabolism produced in vivo by tiadenol, clofibrate, d(2-ethylhexyl)phthalate and other peroxisome proliferators (Berge & Bakke, 1981; Berge et al., 1984; Bakke & Berge, 1982; Moody & Reddy, 1978) . Recently and partly in this study we have shown that addition of tiadenol to cultures of C18 and MCA16 cells enhanced the corresponding enzyme activities . Moreover, in the present study we have shown that addition of TPA to these mouse embryo fibroblasts enhanced the activities of peroxisomal-oxidation, carnitine acetyltransferase, pahnitoyl-CoA hydrolase and catalase (incubation times between 120 and 240h) while mitochondrial and microsomal marker enzymes showed little changes in activity. The first 120 h of cultivation with TPA decreased the catalase activity (Figure 2 ). This observation is in agreement with results from Solanski et al. (1981) reporting that TPA treatment for 16 h decreased the catalase activity in mouse epidermal cells. A similar time course was observed for the palmitoyl-CoA hydrolase activity. The initial inhibition of palmitoyl-CoA hydrolase and catalase activity may be related to the promoting activity of TPA while the stimulation observed during prolonged treatment may be explained, by the growth stimulating and the second stage tumour promoting properties of TPA. The inhibitory effect of cycloheximide on peroxisomal fl-oxidation indicates that the increases produced in cell culture were largely the result of de novo protein synthesis. The low inhibitor effect of cycloheximide on the activity of carnitine acetyltransferase after TPA treatment may be explained by a stimulating effect on the enzyme itself rather than enhanced protein synthesis. Apart from being a peroxisome-associated enzyme, carnitine acetyltransferase is also localized to the mitochondria. The activity of glutamate dehydrogenase was not changed after TPA administration. Thus, these observations further complicate the interpretation of the effect of cycloheximide on carnitine acetyltransferase activity.
The two-stage carcinogenesis process has been studied in several in vitro cell culture assays. The culture system used in the present study is fibroblastic whereas well characterized two-stage systems are also epithelial. The end point analyzed in the present study seemed to be a late irreversible event in carcinogenesis since the foci are irreversibly growing and tumourigenic (Mondal & Heidelberger, 1976) in contrast to the papillomas produced in the well-characterized epidermal system in vivo which are reversibly growing (Burns et al., 1978) and the cells from which are non-tumourigenic (Pera & Gorman, 1984) . Moreover, TPA has not been demonstrated to influence any of the irreversible steps in epidermis in vivo (Verma & Boutwell, 1980) . The first stage of promotion is reversible and melanomas are still promoted by TPA in species where papillomas are not (Sisskin & Barrett, 1981) . Thus, these observations raise the question whether in general promoting agents produce similar effects in in vivo carcinogenesis and in vitro cell transformation.
Although we have not used electron microscopy for assessing these peroxisomal changes, the data suggest that the classical tumour promoter TPA has peroxisomal effects and may be classified as a peroxisome proliferator. Peroxisomes oxidize activated long-chain and medium-chain fatty acids and the removal of two carbons results in generation of one molecule of H202. Thus, H202 is generated as a by-product of the peroxisomal /Boxidation. The time course study demonstrated that the peroxisomal fl-oxidation was enhanced greater and earlier than the catalase activity after TPA treatment e.g. after 180 h of cultivation the peroxisomal fl-oxidation was increased -3-fold while the catalase activity was unaltered. Catalase is not so very effective in destroying H202 at low concentrations (Chance et al., 1979) . Thus, the H202 generated by peroxisomes can escape degradation by catalase. None of the tested carcinogenic peroxisome proliferators has been shown to be mutagenic in bacterial assays (Warren et al., 1980) . However, H202 and related oxygen free radicals are known to be mutagenic in repairdeficient strains of Escherichia coli (Demple et al., 1983) . Furthermore, H202 has also been shown to be carcinogenic in rats and mice. Furthermore, Fahl et al. (1984) have shown that DNA damage is related to increased H202 generation by hypolipidemic drug-induced liver peroxisomes. Recently, we have shown that hypolipidemic drugs such as clofibrate and niadenate, classified as strong peroxisome proliferators, show tumour promoting but no carcinogenic activity in vitro . As clofibrate induces hepatocellular tumours in both mice and rats when chronically administered in the diet , these observations raise the question whether mutagenic metabolites are generated by hypolipidemic drug-induced liver peroxisomes. Induction of hepatocellular tumours may be related to biologically active products of the proliferated peroxisome population rather than a direct drug effect. Therefore, the promoting activity of TPA, classified as a peroxisome proliferator, may be related to biologically active products of the proliferated peroxisome population e.g. H202.
In order to further assess the relevance of the data to tumour promotion and transformation, it will now be of interest to determine whether the number of foci in this culture system show a similar dose-dependence on TPA to the increased activity of peroxisomal #-oxidation.
